Shilpa Medicare Limited (SHILPAMED.NS)
Shilpa Medicare Limited operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Raichur, KA, IN. The stock last traded at $822.00, up 1.85% on the session, giving a market capitalisation of $160.77B. Its beta of 0.29 implies it has historically moved less than the broad market.
Shilpa Medicare Limited, including its various subsidiaries, manufactures and distributes a range of active pharmaceutical ingredients (APIs), intermediate compounds, and finished drug formulations. Operating across India, the United States, Europe, and other international markets, their product lineup encompasses both oncology and non-oncology APIs. The company also innovates with new drug delivery systems, biological products such as peptides, and specialized chemicals. Furthermore, Shilpa Medicare provides contract manufacturing services for diverse dosage forms, including tablets, capsules, liquid and lyophilized injectables, and sterile dry powder injectables. Beyond its pharmaceutical operations, the firm also participates in wind power generation. Founded in 1987, Shilpa Medicare Limited maintains its headquarters in Raichur, India.
Shilpa Medicare Limited is most often compared with the following Healthcare names: